Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

publicrestrictedorigin: hub

Last updated 8/26/2026, 10:04:36 PM

Cite this record

African DSI DataBank. Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation.. AFDSI-PUB-581. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-581 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/41768489/.

BibTeX

@misc{AFDSIPUB581,
  title        = {Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-581}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-581; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/41768489/}
}

AFDSI-PUB-581 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.